Zenlabs Ethica (ZENLABS) | Stock Overview & Key Data
Zenlabs Ethica Performance Comparison
Stock Range
Today's Range
Low: ₹31.53
High: ₹36.82
on August 11, 2025
52 Week Range
Low: ₹27.33
High: ₹52.10
on April 7, 2025
on September 9, 2024
All-Time High: ₹134.90 on September 10, 2018
Explore how other Indian stocks compare to their 52-week ranges: View IN Market 52-Week Insights
Key Statistics
Market Cap
INR214.6M
EPS
0.41
P/E Ratio (TTM)
78.02
Forward P/E
N/A
P/B Ratio
1.99
PEG Ratio
N/A
Div. Yield
N/A
ROE
2.62%
Beta
-0.772
Debt to Equity
121.85
Financial Highlights
Profitability
Gross Margin
32.99%
Operating Margin
2.62%
Profit Margin
0.52%
Returns and Earnings
Return on Assets (TTM)
2.02%
Return on Equity (TTM)
2.62%
EBITDA
INR26.2M
Net Income (TTM)
INR2.7M
Growth
Revenue (TTM)
Revenue Per Share (TTM)
INR78.99
Quarterly Revenue Growth (YoY)
-15.30%
Quarterly Earnings Growth (YoY)
-40.60%
Peer Performance Comparison
| Company | Market Cap | 1W | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|---|---|---|
| Zenlabs Ethica ZENLABS | 214.64M Small-cap | -4.05% | -4.79% | 0.60% | -8.96% | -20.06% | -19.26% | -27.87% | 35.55% |
| Entero Healthcare ENTERO | 51.95B Mid-cap | -1.13% | 5.00% | -4.26% | -7.68% | -10.23% | 4.72% | 12.11% | 12.11% |
| Amwill Health Care AMWILL | 1.19B Small-cap | 0.12% | -11.19% | -28.20% | -36.19% | -36.19% | -39.53% | -39.53% | -39.53% |
| Royal Sense ROYAL | 1.10B Small-cap | -0.97% | -14.37% | -5.51% | -22.64% | -33.01% | 41.38% | 83.91% | 83.91% |
| NOVELIX NOVELIX | 532.40M Small-cap | 2.09% | -5.15% | 50.32% | 57.84% | 57.84% | 57.84% | 57.84% | 57.84% |
| Trimurthi TRIMURTHI | 264.77M Small-cap | 2.09% | -5.15% | 50.32% | 65.68% | 73.91% | 111.27% | 425.00% | 1,128.07% |
Ownership & Short Interest
Insider Ownership
64.99%
Institutional Ownership
0.00%
Shares Short
N/A
Short Ratio
N/A
Short % of Shares Outstanding
N/A
Average 10-Day Volume
2K
Average 90-Day Volume
9K
Zenlabs Ethica Recurring Investment / Dollar-Cost Averaging Calculator
Calculate how a regular investment in Zenlabs Ethica would have performed over time.
Note: This calculator is for informational purposes only and does not consider taxes, fees, or other costs associated with investing.
Frequently Asked Questions
- What is ZENLABS's 52-week high and low?
- In the last 52 weeks, Zenlabs Ethica reached a high of ₹52.10 (on September 9, 2024) and a low of ₹27.33 (on April 7, 2025).
- What is the market cap and P/E ratio for ZENLABS?
- Curious about Zenlabs Ethica's size and valuation? Its market capitalization stands at 214.64M. When it comes to valuation, the P/E ratio (trailing twelve months) is 78.02, and the forward P/E (looking ahead) is N/A.
- Does ZENLABS pay dividends? If so, what's the yield?
- As for dividends, Zenlabs Ethica isn't currently offering a significant yield, or that specific data isn't available right now.
- Who are Zenlabs Ethica's main competitors or similar companies to consider before investing?
When looking at Zenlabs Ethica, it can be helpful to see how it compares to other players in its field. Here are a few similar companies or key competitors:
Company Mkt Cap Sector Industry 1Y Return 3Y Return Entero Healthcare
ENTERO51.95B Healthcare Medical Distribution 4.72% 12.11% Amwill Health Care
AMWILL1.19B Healthcare Medical Distribution -39.53% -39.53% Royal Sense
ROYAL1.10B Healthcare Medical Distribution 41.38% 83.91% NOVELIX
NOVELIX532.40M Healthcare Medical Distribution 57.84% 57.84% Trimurthi
TRIMURTHI264.77M Healthcare Medical Distribution 111.27% 425.00% For a more comprehensive list, please see the Peer Performance Comparison table on this page.
- What are the key financial health indicators for Zenlabs Ethica Ltd.? (e.g., ROE, Debt/Equity)
- To get a sense of Zenlabs Ethica's financial health, here are a few key indicators: its Return on Equity (ROE) over the last twelve months is 2.62%, the Debt to Equity ratio from the most recent quarter is 121.85, and its Gross Profit Margin stands at 32.99%.
- What is the recent revenue and earnings growth for ZENLABS?
- Looking at Zenlabs Ethica's growth, its revenue over the trailing twelve months (TTM) was INR514M. Compared to the same quarter last year (YoY), quarterly revenue grew by -15.30%, and quarterly earnings saw a YoY growth of -40.60%.
- How much of ZENLABS stock is held by insiders and institutions?
- Wondering who owns Zenlabs Ethica stock? Company insiders (like executives and directors) hold about 64.99% of the shares, while institutional investors (such as mutual funds and pension funds) own approximately 0.00%.
For more common questions about our data, please visit our About Data page.
Data is provided for informational purposes only. Devyara does not guarantee the accuracy of the data displayed.